Europe Degenerative Disc Disease Treatment Market Size, Share & Trends Analysis Report By Route of Administration, By Drugs, By End Use, By Treatment Type, By Country and Growth Forecast, 2024

List of Tables

The Europe Degenerative Disc Disease Treatment Market would witness market growth of 5.2% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Degenerative Disc Disease Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,917 million by 2031. The UK market is exhibiting a CAGR of 4.3% during (2024 - 2031). Additionally, The France market would experience a CAGR of 6% during (2024 - 2031).

Injections of corticosteroids into the epidural space around the affected disc can temporarily relieve pain and inflammation, particularly when conservative measures are insufficient. These injections target the small joints located between vertebrae in the spine. They can help alleviate pain originating from facet joint arthritis or dysfunction associated with DDD.

Furthermore, a surgical procedure to remove the damaged or herniated portion of a spinal disc that is pressing on nerve roots or the spinal cord. It aims to relieve nerve compression and associated symptoms such as sciatica. Fusion surgery involves permanently joining two or more vertebrae using bone grafts or synthetic materials. It stabilizes the spine and reduces pain by eliminating motion between vertebrae at the affected disc level. This procedure involves removing and replacing the damaged disc with an artificial disc device. It aims to maintain spinal motion while alleviating pain and preserving natural spine biomechanics.

Increasing patient awareness about treatment options for degenerative disc disease and efforts to improve access to healthcare services drive demand for effective therapies in Europe's market. Collaborations between research institutions, medical centers, and pharmaceutical companies in Europe contribute to developing new therapeutic approaches and medications for degenerative disc disease, expanding the market's treatment options. The economic burden of musculoskeletal disorders, including costs related to productivity loss and disability, underscores the importance of effective DDD treatments in Europe's healthcare landscape. Addressing these impacts drives investment in innovative solutions. In concision, the high prevalence of musculoskeletal disorders in Europe is driving the market's growth.

Based on Route of Administration, the market is segmented into Oral, and Injectable. Based on Drugs, the market is segmented into NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), Acetaminophen, Muscle Relaxants, and Steroids. Based on End Use, the market is segmented into Hospitals, Clinics, and Others. Based on Treatment Type, the market is segmented into Physical Therapy, Occupational Therapy, Special Exercises, Weight Loss Surgery, and Medications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

Medtronic PLC
AstraZeneca PLC
Pfizer, Inc.
Novartis AG
Eli Lilly And Company
Spine Wave Inc.
B. Braun Melsungen AG (Aesculap, Inc.)
DiscGenics, Inc.
Spine BioPharma Inc.
Stryker Corporation

Europe Degenerative Disc Disease Treatment Market Report Segmentation

By Route of Administration

Oral
Injectable

By Drugs

NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)
Acetaminophen
Muscle Relaxants
Steroids

By End Use

Hospitals
Clinics
Others

By Treatment Type

Physical Therapy
Occupational Therapy
Special Exercises
Weight Loss Surgery
Medications

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Degenerative Disc Disease Treatment Market, by Route of Administration
- 1.4.2 Europe Degenerative Disc Disease Treatment Market, by Drugs
- 1.4.3 Europe Degenerative Disc Disease Treatment Market, by End Use
- 1.4.4 Europe Degenerative Disc Disease Treatment Market, by Treatment Type
- 1.4.5 Europe Degenerative Disc Disease Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Europe Degenerative Disc Disease Treatment Market by Route of Administration

4.1 Europe Oral Market by Country
4.2 Europe Injectable Market by Country

Chapter 5. Europe Degenerative Disc Disease Treatment Market by Drugs

5.1 Europe NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) Market by Country
5.2 Europe Acetaminophen Market by Country
5.3 Europe Muscle Relaxants Market by Country
5.4 Europe Steroids Market by Country

Chapter 6. Europe Degenerative Disc Disease Treatment Market by End Use

6.1 Europe Hospitals Market by Country
6.2 Europe Clinics Market by Country
6.3 Europe Others Market by Country

Chapter 7. Europe Degenerative Disc Disease Treatment Market by Treatment Type

7.1 Europe Physical Therapy Market by Country
7.2 Europe Occupational Therapy Market by Country
7.3 Europe Special Exercises Market by Country
7.4 Europe Weight Loss Surgery Market by Country
7.5 Europe Medications Market by Country

Chapter 8. Europe Degenerative Disc Disease Treatment Market by Country

8.1 Germany Degenerative Disc Disease Treatment Market
- 8.1.1 Germany Degenerative Disc Disease Treatment Market by Route of Administration
- 8.1.2 Germany Degenerative Disc Disease Treatment Market by Drugs
- 8.1.3 Germany Degenerative Disc Disease Treatment Market by End Use
- 8.1.4 Germany Degenerative Disc Disease Treatment Market by Treatment Type
8.2 UK Degenerative Disc Disease Treatment Market
- 8.2.1 UK Degenerative Disc Disease Treatment Market by Route of Administration
- 8.2.2 UK Degenerative Disc Disease Treatment Market by Drugs
- 8.2.3 UK Degenerative Disc Disease Treatment Market by End Use
- 8.2.4 UK Degenerative Disc Disease Treatment Market by Treatment Type
8.3 France Degenerative Disc Disease Treatment Market
- 8.3.1 France Degenerative Disc Disease Treatment Market by Route of Administration
- 8.3.2 France Degenerative Disc Disease Treatment Market by Drugs
- 8.3.3 France Degenerative Disc Disease Treatment Market by End Use
- 8.3.4 France Degenerative Disc Disease Treatment Market by Treatment Type
8.4 Russia Degenerative Disc Disease Treatment Market
- 8.4.1 Russia Degenerative Disc Disease Treatment Market by Route of Administration
- 8.4.2 Russia Degenerative Disc Disease Treatment Market by Drugs
- 8.4.3 Russia Degenerative Disc Disease Treatment Market by End Use
- 8.4.4 Russia Degenerative Disc Disease Treatment Market by Treatment Type
8.5 Spain Degenerative Disc Disease Treatment Market
- 8.5.1 Spain Degenerative Disc Disease Treatment Market by Route of Administration
- 8.5.2 Spain Degenerative Disc Disease Treatment Market by Drugs
- 8.5.3 Spain Degenerative Disc Disease Treatment Market by End Use
- 8.5.4 Spain Degenerative Disc Disease Treatment Market by Treatment Type
8.6 Italy Degenerative Disc Disease Treatment Market
- 8.6.1 Italy Degenerative Disc Disease Treatment Market by Route of Administration
- 8.6.2 Italy Degenerative Disc Disease Treatment Market by Drugs
- 8.6.3 Italy Degenerative Disc Disease Treatment Market by End Use
- 8.6.4 Italy Degenerative Disc Disease Treatment Market by Treatment Type
8.7 Rest of Europe Degenerative Disc Disease Treatment Market
- 8.7.1 Rest of Europe Degenerative Disc Disease Treatment Market by Route of Administration
- 8.7.2 Rest of Europe Degenerative Disc Disease Treatment Market by Drugs
- 8.7.3 Rest of Europe Degenerative Disc Disease Treatment Market by End Use
- 8.7.4 Rest of Europe Degenerative Disc Disease Treatment Market by Treatment Type

Chapter 9. Company Profiles

9.1 Medtronic PLC
- 9.1.1 Company overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Partnerships, Collaborations, and Agreements:
  - 9.1.5.2 Trail and Approvals:
- 9.1.6 SWOT Analysis
9.2 AstraZeneca PLC
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 SWOT Analysis
9.3 Pfizer, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Regional & Segmental Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 SWOT Analysis
9.4 Novartis AG
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
  - 9.4.5.1 Partnerships, Collaborations, and Agreements:
  - 9.4.5.2 Acquisition and Mergers:
- 9.4.6 SWOT Analysis
9.5 Eli Lilly And Company
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 SWOT Analysis
9.6 Spine Wave Inc.
- 9.6.1 Company Overview
9.7 B. Braun Melsungen AG (Aesculap, Inc.)
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 DiscGenics, Inc.
- 9.8.1 Company Overview
9.9 Spine BioPharma Inc.
- 9.9.1 Company Overview
9.10. Stryker Corporation
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 Europe Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 2 Europe Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 3 Europe Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 4 Europe Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 5 Europe Oral Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Oral Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Injectable Market by Country, 2020 - 2023, USD Million
TABLE 8 Europe Injectable Market by Country, 2024 - 2031, USD Million
TABLE 9 Europe Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 10 Europe Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 11 Europe NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) Market by Country, 2020 - 2023, USD Million
TABLE 12 Europe NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) Market by Country, 2024 - 2031, USD Million
TABLE 13 Europe Acetaminophen Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe Acetaminophen Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Muscle Relaxants Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Muscle Relaxants Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Steroids Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Steroids Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 20 Europe Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 21 Europe Hospitals Market by Country, 2020 - 2023, USD Million
TABLE 22 Europe Hospitals Market by Country, 2024 - 2031, USD Million
TABLE 23 Europe Clinics Market by Country, 2020 - 2023, USD Million
TABLE 24 Europe Clinics Market by Country, 2024 - 2031, USD Million
TABLE 25 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 26 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 27 Europe Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 28 Europe Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 29 Europe Physical Therapy Market by Country, 2020 - 2023, USD Million
TABLE 30 Europe Physical Therapy Market by Country, 2024 - 2031, USD Million
TABLE 31 Europe Occupational Therapy Market by Country, 2020 - 2023, USD Million
TABLE 32 Europe Occupational Therapy Market by Country, 2024 - 2031, USD Million
TABLE 33 Europe Special Exercises Market by Country, 2020 - 2023, USD Million
TABLE 34 Europe Special Exercises Market by Country, 2024 - 2031, USD Million
TABLE 35 Europe Weight Loss Surgery Market by Country, 2020 - 2023, USD Million
TABLE 36 Europe Weight Loss Surgery Market by Country, 2024 - 2031, USD Million
TABLE 37 Europe Medications Market by Country, 2020 - 2023, USD Million
TABLE 38 Europe Medications Market by Country, 2024 - 2031, USD Million
TABLE 39 Europe Degenerative Disc Disease Treatment Market by Country, 2020 - 2023, USD Million
TABLE 40 Europe Degenerative Disc Disease Treatment Market by Country, 2024 - 2031, USD Million
TABLE 41 Germany Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 42 Germany Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 43 Germany Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 44 Germany Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 45 Germany Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 46 Germany Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 47 Germany Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 48 Germany Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 49 Germany Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 50 Germany Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 51 UK Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 52 UK Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 53 UK Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 54 UK Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 55 UK Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 56 UK Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 57 UK Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 58 UK Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 59 UK Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 60 UK Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 61 France Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 62 France Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 63 France Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 64 France Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 65 France Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 66 France Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 67 France Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 68 France Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 69 France Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 70 France Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 71 Russia Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 72 Russia Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 73 Russia Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 74 Russia Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 75 Russia Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 76 Russia Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 77 Russia Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 78 Russia Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 79 Russia Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 80 Russia Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 81 Spain Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 82 Spain Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 83 Spain Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 84 Spain Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 85 Spain Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 86 Spain Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 87 Spain Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 88 Spain Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 89 Spain Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 90 Spain Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 91 Italy Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 92 Italy Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 93 Italy Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 94 Italy Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 95 Italy Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 96 Italy Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 97 Italy Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 98 Italy Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 99 Italy Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 100 Italy Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 101 Rest of Europe Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
TABLE 102 Rest of Europe Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
TABLE 103 Rest of Europe Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
TABLE 104 Rest of Europe Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
TABLE 105 Rest of Europe Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 106 Rest of Europe Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 107 Rest of Europe Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
TABLE 108 Rest of Europe Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
TABLE 109 Rest of Europe Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
TABLE 110 Rest of Europe Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
TABLE 111 Key Information - Medtronic PLC
TABLE 112 Key Information - AstraZeneca PLC
TABLE 113 Key Information - Pfizer, Inc.
TABLE 114 Key Information - Novartis AG
TABLE 115 Key Information - Eli Lilly And Company
TABLE 116 Key Information - Spine Wave Inc.
TABLE 117 Key Information - B. Braun Melsungen AG
TABLE 118 Key Information - DiscGenics, Inc.
TABLE 119 Key Information - Spine BioPharma Inc.
TABLE 120 Key Information - Stryker Corporation

Europe Degenerative Disc Disease Treatment Market Size, Share & Trends Analysis Report By Route of Administration, By Drugs, By End Use, By Treatment Type, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents